Thus, in order to conceive more effective and specific treatment, we developed a new gene oriented therapy by siRNA to target RET/PTC3 rearrangement, which is only present in the tumour cells and not in the surrounding normal cells. This evidence concerns the gene NCOA4 and neoplasm.